Aptarion Biotech
- Biotech or pharma, therapeutic R&D
Aptarion is a drug development company. Our lead drug candidate AON-D21 is currently being tested in a Phase 2 clinical trial in severe community-acquired pneumonia to modulate overshooting immune responses. Strong preclinical data in lung cancer models provide upside potential in oncology.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}